Mieke Bus

46 Chapter 3 Reference list 1. Sudakoff GS, Dunn DP, Guralnick ML, Hellman RS, Eastwood D, SeeWA. Multidetector com- puterized tomography urography as the primary imaging modality for detecting urinary tract neoplasms in patients with asymptomatic hematuria. JUrol. 2008;179(3):862-7. 2. Messer J, Shariat SF, Brien JC, Herman MP, Ng CK, Scherr DS, et al. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carci- noma. BJUInt. 2011;108(5):701-5. 3. Xu AD, Ng CS, Kamat A, Grossman HB, Dinney C, Sandler CM. Significance of upper uri- nary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms. AJR AmJRoentgenol. 2010;195(4):959-65. 4. Tavora F, Fajardo DA, Lee TK, Lotan T, Miller JS, Miyamoto H, et al. Small endoscopic biop- sies of the ureter and renal pelvis: pathologic pitfalls. AmJSurgPathol. 2009;33(10):1540-6. 5. Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH. High rate of patho- logic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2012;79(3):615-9. 6. Roupret M, Babjuk M Fau - Comperat E, Comperat E Fau - Zigeuner R, Zigeuner R Fau - Sylvester R, Sylvester R Fau - Burger M, Burger M Fau - Cowan N, et al. European guide- lines on upper tract urothelial carcinomas: 2013 update. (1873-7560 (Electronic)). 7. Cauberg EC, de Bruin DM, Faber DJ, van Leeuwen TG, de la Rosette JJ, de Reijke TM. A new generation of optical diagnostics for bladder cancer: technology, diagnostic accu- racy, and future applications. EurUrol. 2009;56(2):287-96. 8. Liu JJ, Droller MJ, Liao JC. New optical imaging technologies for bladder cancer: consid- erations and perspectives. JUrol. 2012;188(2):361-8. 9. McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 2009;374(9695):1105-12. 10. McCulloch P. The IDEAL recommendations and urological innovation. World J Urol. 2011;29(3):331-6. 11. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMCMedResMethodol. 2006;6:9. 12. Howick J, Chalmers I, Glasziou, Greenhalgh T, Heneghan C, Liberati A, et al. Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Back- ground Document) 2014 [updated 2014. Available from: http://www.cebm.net/index. aspx?o=5653. 13. Cauberg EC, Mamoulakis C, de la Rosette JJ, de Reijke TM. Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate. World J Urol. 2011;29(4):503-9.